NCT07023094View on ClinicalTrials.gov

PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

May 30, 2026

Study Completion Date

June 30, 2026

Conditions
Hip DiseaseHip DysplasiaHip Arthropathy
Interventions
DRUG

Ropivacaine 0.2% for PENG Block

U-S guided PENG (0.4 mL/kg) with 0.2% ropivacaine

DRUG

Ropivacaine 0.2% for LFCB

LFCB (0.1 mL/kg) with 0.2% ropivacaine

DRUG

Ropivacaine 0.2% for L-ESPB

Lumbar ESPB (0.25ml/kg) with 0.2% ropivacaine

DRUG

Ropivacaine 0.2% for S-ESPB

Sacral ESPB (0.25ml/kg) with 0.2% ropivacaine

Trial Locations (1)

Unknown

RECRUITING

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER